23 results
S-3
EX-1.2
ACHV
Achieve Life Sciences Inc.
Shelf registration
21 Dec 21
5:04pm
8-K
EX-1.1
ACHV
Achieve Life Sciences Inc.
25 May 21
Achieve Life Sciences Announces Proposed Underwritten Public Offering
4:11pm
SC 13G/A
EX-1
ACHV
Achieve Life Sciences Inc.
17 Feb 21
ACHIEVE LIFE SCIENCES / PURA VIDA INVESTMENTS ownership change
12:00am
SC 13G/A
EX-1
Packer Paul
12 Feb 21
ACHIEVE LIFE SCIENCES / PACKER PAUL ownership change
4:05pm
SC 13G
EX-1
Packer Paul
4 Dec 20
ACHIEVE LIFE SCIENCES / PACKER PAUL ownership change
1:17pm
8-K
EX-1.1
nx2nc7ko2oasw
5 Aug 20
Entry into a Material Definitive Agreement
12:00am
SC 13G
EX-1
8o3hg9rb4fy3w
27 Dec 19
Achieve Life Sciences, Inc.
4:32pm
8-K
EX-1.1
8bbrm
20 Dec 19
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-1.1
2f4ao0lxg3ndzohjgkdx
7 Jun 19
Entry into a Material Definitive Agreement
4:21pm
SC 13G
EX-1
vg5898hdicif7gu3
28 May 19
Achieve Life Sciences, Inc.
9:31am
8-K
EX-1.1
ms94vyg5a90a9tm5o
1 Oct 18
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
5:11pm
8-K
EX-1.1
moxtr4sk
20 Jun 18
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
8:45am
8-K
EX-1.1
knzj39xr qe
30 Apr 15
OncoGenex Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC
12:00am
8-K
EX-1.1
5v3jv
27 Jun 14
OncoGenex Pharmaceuticals Announces Pricing of $24 Million
12:00am
8-K
EX-1.1
t2ahgin26b5neceu
18 Jun 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
73s8 hjjztlkz
16 Mar 12
OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering
12:00am